Use of antipsychotic medication with weight-inducing potential in first-episode psychosis

Maren Johanne Landsem, Gunnar Morken, Morten Brix Schou · 2026

Read Use of antipsychotic medication with weight-inducing potential in first-episode psychosis by Maren Johanne Landsem, Gunnar Morken, Morten Brix Schou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13448547.txt.

Description

Maren Landsem, Gunnar Morken and Morten Schou audit first antipsychotic choices in first-episode psychosis at a Norwegian university hospital in a 2026 cohort study. Guidelines advise against starting with drugs carrying high weight-gain risk, since weight gain distresses patients and drives stopping treatment. Yet reported starting rates for such drugs run high internationally, and local practice plus its predictors needed checking.

All two hundred thirty-eight patients treated from 2012 to 2016 were traced through records at start, one year and two years. Over half began on a high weight-risk drug, about a third on a lower-risk option, and the rest on none at initiation. Older age, emergency referral and greater illness severity each raised the chance of a high-risk start. Focused effort on those groups is urged to bring practice in line with guidelines.

Catalog record

CREATORMaren Johanne Landsem, Gunnar Morken, Morten Brix Schou
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32304
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13448547

Browse the full library · About the Tower of Babel